Pre-order Enquiry
Request Free Sample
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18416592 | Publishing Date : 01-Jun-2021
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Product Overview
1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Type
1.2.1 Afatinib Dimaleate
1.2.2 Dacomitinib
1.2.3 Neratinib
1.2.4 Neucardin
1.2.5 Others
1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Type
1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021)
2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Company
2.1 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Sales (2016-2021)
2.2 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (2016-2021)
2.3 Global Top Players Receptor Tyrosine Protein Kinase Targeted Drugs Price (2016-2021)
2.4 Global Top Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
2.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
2.8 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Receptor Tyrosine Protein Kinase Targeted Drugs Status and Outlook by Region
3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Region
3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Region
3.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Receptor Tyrosine Protein Kinase Targeted Drugs by Application
4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiovascular
4.1.3 Central Nervous System
4.1.4 Others
4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Application
4.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021)
5 North America Receptor Tyrosine Protein Kinase Targeted Drugs by Country
5.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
5.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021)
5.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
5.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027)
6 Europe Receptor Tyrosine Protein Kinase Targeted Drugs by Country
6.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
6.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021)
6.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
6.2.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs by Region
7.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2022-2027)
8 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs by Country
8.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
8.1.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
8.2.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs by Country
9.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Receptor Tyrosine Protein Kinase Targeted Drugs Business
10.1 Aslan Pharmaceuticals Pte Ltd
10.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
10.1.2 Aslan Pharmaceuticals Pte Ltd Introduction and Business Overview
10.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.1.5 Aslan Pharmaceuticals Pte Ltd Recent Development
10.2 Boehringer Ingelheim GmbH
10.2.1 Boehringer Ingelheim GmbH Corporation Information
10.2.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.2.5 Boehringer Ingelheim GmbH Recent Development
10.3 GamaMabs Pharma SA
10.3.1 GamaMabs Pharma SA Corporation Information
10.3.2 GamaMabs Pharma SA Introduction and Business Overview
10.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.3.5 GamaMabs Pharma SA Recent Development
10.4 Hanmi Pharmaceuticals Co Ltd
10.4.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
10.4.2 Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview
10.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.4.5 Hanmi Pharmaceuticals Co Ltd Recent Development
10.5 Jiangsu Kanion Pharmaceutical Co Ltd
10.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
10.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Introduction and Business Overview
10.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
10.6 Minerva Neurosciences Inc
10.6.1 Minerva Neurosciences Inc Corporation Information
10.6.2 Minerva Neurosciences Inc Introduction and Business Overview
10.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.6.5 Minerva Neurosciences Inc Recent Development
10.7 Pfizer Inc
10.7.1 Pfizer Inc Corporation Information
10.7.2 Pfizer Inc Introduction and Business Overview
10.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.7.5 Pfizer Inc Recent Development
10.8 Puma Biotechnology Inc
10.8.1 Puma Biotechnology Inc Corporation Information
10.8.2 Puma Biotechnology Inc Introduction and Business Overview
10.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.8.5 Puma Biotechnology Inc Recent Development
10.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
10.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
10.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Introduction and Business Overview
10.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
10.10 XuanZhu Pharma Co Ltd
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
10.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 XuanZhu Pharma Co Ltd Recent Development
10.11 Zensun (Shanghai) Sci & Tech Co Ltd
10.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
10.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Introduction and Business Overview
10.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
11.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors
12.3 Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of Afatinib Dimaleate
Table 2. Major Company of Dacomitinib
Table 3. Major Company of Neratinib
Table 4. Major Company of Neucardin
Table 5. Major Company of Others
Table 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (K Pcs)
Table 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2016-2021)
Table 9. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US& Million)
Table 10. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share in Value by Type (2016-2021)
Table 11. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2016-2021) & (USD/Pcs)
Table 12. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2022-2027) & (K Pcs)
Table 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2022-2027)
Table 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2022-2027) & (US$ Million)
Table 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2022-2027)
Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2022-2027) & (USD/Pcs)
Table 17. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (K Pcs)
Table 18. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million)
Table 19. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021)
Table 20. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million)
Table 21. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021)
Table 22. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million)
Table 23. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021)
Table 24. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million)
Table 25. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021)
Table 26. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million)
Table 27. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Company (2016-2021) & (K Pcs)
Table 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Company (2016-2021)
Table 29. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Company (2016-2021)
Table 31. Global Market Receptor Tyrosine Protein Kinase Targeted Drugs Price by Company (2016-2021) & (USD/Pcs)
Table 32. Global Receptor Tyrosine Protein Kinase Targeted Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2020
Table 35. Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
Table 36. Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 39. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (K Pcs)
Table 40. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2016-2021)
Table 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (US$ Million)
Table 42. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2016-2021)
Table 43. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 44. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (K Pcs)
Table 45. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2022-2027)
Table 46. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (US$ Million)
Table 47. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2022-2027)
Table 48. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027)
Table 49. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 50. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (K Pcs)
Table 51. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2016-2021)
Table 52. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million)
Table 53. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2016-2021)
Table 54. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2016-2021) & (USD/Pcs)
Table 55. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2022-2027) & (K Pcs)
Table 56. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2022-2027)
Table 57. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2022-2027) & (US$ Million)
Table 58. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2022-2027)
Table 59. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2022-2027) & (USD/Pcs)
Table 60. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs)
Table 61. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million)
Table 62. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Table 63. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs)
Table 64. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million)
Table 65. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Table 66. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs)
Table 67. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million)
Table 68. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Table 69. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs)
Table 70. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million)
Table 71. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Table 72. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs)
Table 73. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million)
Table 74. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Table 75. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs)
Table 76. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021)
Table 77. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million)
Table 78. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021)
Table 79. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs)
Table 80. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027)
Table 81. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million)
Table 82. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027)
Table 83. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs)
Table 84. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021)
Table 85. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million)
Table 86. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021)
Table 87. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs)
Table 88. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027)
Table 89. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million)
Table 90. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027)
Table 91. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (K Pcs)
Table 92. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2016-2021)
Table 93. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (US$ Million)
Table 94. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2016-2021)
Table 95. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (K Pcs)
Table 96. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2022-2027)
Table 97. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (US$ Million)
Table 98. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2022-2027)
Table 99. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs)
Table 100. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021)
Table 101. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million)
Table 102. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021)
Table 103. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs)
Table 104. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027)
Table 105. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million)
Table 106. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027)
Table 107. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs)
Table 108. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021)
Table 109. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million)
Table 110. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021)
Table 111. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs)
Table 112. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027)
Table 113. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million)
Table 114. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027)
Table 115. Aslan Pharmaceuticals Pte Ltd Corporation Information
Table 116. Aslan Pharmaceuticals Pte Ltd Introduction and Business Overview
Table 117. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 119. Aslan Pharmaceuticals Pte Ltd Recent Development
Table 120. Boehringer Ingelheim GmbH Corporation Information
Table 121. Boehringer Ingelheim GmbH Introduction and Business Overview
Table 122. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 124. Boehringer Ingelheim GmbH Recent Development
Table 125. GamaMabs Pharma SA Corporation Information
Table 126. GamaMabs Pharma SA Introduction and Business Overview
Table 127. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 129. GamaMabs Pharma SA Recent Development
Table 130. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 131. Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview
Table 132. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 134. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 135. Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
Table 136. Jiangsu Kanion Pharmaceutical Co Ltd Introduction and Business Overview
Table 137. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 139. Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
Table 140. Minerva Neurosciences Inc Corporation Information
Table 141. Minerva Neurosciences Inc Introduction and Business Overview
Table 142. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 144. Minerva Neurosciences Inc Recent Development
Table 145. Pfizer Inc Corporation Information
Table 146. Pfizer Inc Introduction and Business Overview
Table 147. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 148. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 149. Pfizer Inc Recent Development
Table 150. Puma Biotechnology Inc Corporation Information
Table 151. Puma Biotechnology Inc Introduction and Business Overview
Table 152. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 153. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 154. Puma Biotechnology Inc Recent Development
Table 155. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
Table 156. Shanghai Fosun Pharmaceutical (Group) Co Ltd Introduction and Business Overview
Table 157. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 159. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
Table 160. XuanZhu Pharma Co Ltd Corporation Information
Table 161. XuanZhu Pharma Co Ltd Introduction and Business Overview
Table 162. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 164. XuanZhu Pharma Co Ltd Recent Development
Table 165. Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
Table 166. Zensun (Shanghai) Sci & Tech Co Ltd Introduction and Business Overview
Table 167. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 169. Zensun (Shanghai) Sci & Tech Co Ltd Recent Development
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Receptor Tyrosine Protein Kinase Targeted Drugs Market Trends
Table 173. Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers
Table 174. Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges
Table 175. Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints
Table 176. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
Table 177. Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Customers
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase Targeted Drugs Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Status and Outlook (2016-2027) & (K Pcs)
Figure 5. Product Picture of Afatinib Dimaleate
Figure 6. Global Afatinib Dimaleate Sales YoY Growth (2016-2021) & (K Pcs)
Figure 7. Product Picture of Dacomitinib
Figure 8. Global Dacomitinib Sales YoY Growth (2016-2021) & (K Pcs)
Figure 9. Product Picture of Neratinib
Figure 10. Global Neratinib Sales YoY Growth (2016-2021) & (K Pcs)
Figure 11. Product Picture of Neucardin
Figure 12. Global Neucardin Sales YoY Growth (2016-2021) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2016-2021) & (K Pcs)
Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2027) & (US$ Million)
Figure 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2016-2021)
Figure 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2016-2021)
Figure 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2022-2027)
Figure 19. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2022-2027)
Figure 20. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020
Figure 21. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020
Figure 22. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020
Figure 23. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020
Figure 24. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020
Figure 25. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020
Figure 26. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020
Figure 27. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020
Figure 28. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020
Figure 29. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Sales in 2020
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue in 2020
Figure 32. Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 33. Product Picture of Oncology
Figure 34. Global Oncology Sales YoY Growth (2016-2027) & (K Pcs)
Figure 35. Product Picture of Cardiovascular
Figure 36. Global Cardiovascular Sales YoY Growth (2016-2027) & (K Pcs)
Figure 37. Product Picture of Central Nervous System
Figure 38. Global Central Nervous System Sales YoY Growth (2016-2027) & (K Pcs)
Figure 39. Product Picture of Others
Figure 40. Global Others Sales YoY Growth (2016-2027) & (K Pcs)
Figure 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2027) & (US$ Million)
Figure 42. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2016-2021)
Figure 43. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2016-2021)
Figure 44. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2022-2027)
Figure 45. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application in 2020
Figure 46. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Figure 47. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020
Figure 48. Key Raw Materials Price
Figure 49. Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Structure
Figure 50. Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Keyplayers in Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
Aslan Pharmaceuticals Pte LtdBoehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
